BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37774093)

  • 1. Maternally derived antibody titer dynamics and risk of hospitalized infant dengue disease.
    O'Driscoll M; Buddhari D; Huang AT; Waickman A; Kaewhirun S; Iamsirithaworn S; Khampaen D; Farmer A; Fernandez S; Rodriguez-Barraquer I; Srikiatkhachorn A; Thomas S; Endy T; Rothman AL; Anderson K; Cummings DAT; Salje H
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2308221120. PubMed ID: 37774093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.
    Castanha PM; Braga C; Cordeiro MT; Souza AI; Silva CD; Martelli CM; van Panhuis WG; Nascimento EJ; Marques ET
    J Infect Dis; 2016 Jul; 214(2):265-72. PubMed ID: 27056951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants.
    Chau TN; Hieu NT; Anders KL; Wolbers M; Lien le B; Hieu LT; Hien TT; Hung NT; Farrar J; Whitehead S; Simmons CP
    J Infect Dis; 2009 Dec; 200(12):1893-900. PubMed ID: 19911991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
    Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N
    Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
    Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
    PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
    de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
    PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan.
    Ma Y; Li M; Xie L; Gao N; Fan D; Feng K; Yao Y; Zhou Y; Sheng Z; Zhou H; Chen H; An J
    Virol Sin; 2022 Feb; 37(1):19-29. PubMed ID: 35234619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge.
    O'Donnell KL; Espinosa DA; Puerta-Guardo H; Biering SB; Warnes CM; Schiltz J; Nilles ML; Li J; Harris E; Bradley DS
    Antiviral Res; 2020 Nov; 183():104923. PubMed ID: 32979401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study.
    Guignard A; Haguinet F; Wéry S; Kerdpanich P
    Asia Pac J Public Health; 2019 May; 31(4):288-295. PubMed ID: 31307216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
    Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.
    Wegman AD; Fang H; Rothman AL; Thomas SJ; Endy TP; McCracken MK; Currier JR; Friberg H; Gromowski GD; Waickman AT
    Front Immunol; 2021; 12():777672. PubMed ID: 34899736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human antibody response to dengue virus infection.
    Wahala WM; Silva AM
    Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics.
    Clapham H; Cummings DA; Nisalak A; Kalayanarooj S; Thaisomboonsuk B; Klungthong C; Fernandez S; Srikiatkhachorn A; Macareo LR; Lessler J; Reiser J; Yoon IK
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004262. PubMed ID: 26658730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.